510(k) Report

510(k) · Cleared

Cleared

Acl Top 970 CL

K233790510(k) SpecialCleared Dec 29, 202331-day reviewClass II21 CFR 864.5425

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Instrumentation Laboratory · JPA System, Multipurpose For In Vitro Coagulation Studies

Cleared on Dec 29, 2023 as substantially equivalent to K150877 (Instrumentation Laboratory CO, 2015) after a 31-day review. Its family tree reaches back 6 generations to 2000.

Decided
Dec 29, 2023
Review
31 days
Class
Class II
Product code
JPA
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K002400 (2000). No later device cites it as a predicate yet.

  1. Root · 6 generations backK002400 Modification of Acl AdvanceInstrumentation Laboratory CO · 2000 · Recalled
  2. 5 generations backK033414 Acl Top Model, TopInstrumentation Laboratory CO · 2004 · Recalled
  3. 4 generations backK063679 Acl TopInstrumentation Laboratory CO · 2007 · Recalled
  4. 3 generations backK073377 Acl Top (with System Software V3.0.0)Instrumentation Laboratory CO · 2008
  5. 2 generations backK091980 Acl Top 700 LasInstrumentation Laboratory CO · 2009 · Recalled
  6. 1 generation backK150877 Acl Top Family 50 Series: Acl Top 350 CTS; Acl Top 550 CTS; Acl Top…Instrumentation Laboratory CO · 2015 · Recalled
  7. This deviceK233790 Acl Top 970 CLInstrumentation Laboratory · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K002400Modification of Acl AdvanceInstrumentation Laboratory CO20002
−5K033414Acl Top Model, TopInstrumentation Laboratory CO20041
−4K063679Acl TopInstrumentation Laboratory CO20071
−3K073377Acl Top (with System Software V3.0.0)Instrumentation Laboratory CO2008—
−2K091980Acl Top 700 LasInstrumentation Laboratory CO200924
−1K150877Acl Top Family 50 Series: Acl Top 350 CTS; Acl Top 550 CTS; Acl Top 750; Acl…Instrumentation Laboratory CO20151
0 (this device)K233790Acl Top 970 CLInstrumentation Laboratory2023—
FIG. 1 — Lineage of K233790, 2000–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JPA device

  1. #1 K243858 TEG 6s Hemostasis System Citrated: K, KH, RT…score 12.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K150877Acl Top Family 50 Series: Acl Top 350 CTS; Acl Top 550 CTS; Acl Top 750; Acl Top 750…
Summary page 4
…erfen.com Preparation Date December 29, 2023 Device Trade Name ACL TOP 970 CL Predicate Device ACL TOP Family 50 Series K150877 Regulation Section No. 21 CFR 864.5425…
Instrumentation Laboratory CO20151
†K231031ACL TOP Family 70 SeriesInstrumentation Laboratory Company2023—
†K221359ACL TOP 970 CL, HemosIL CL Anti-Cardiolipin IgM, HemosIL CL Anti-ß2 Glycoprotein-I IgMInstrumentation Laboratory CO2023—
†K172903HemosIL D-Dimer HS 500Instrumentation Laboratory CO2017—
†K034007Hemosil Factor Viii Deficient PlasmaInstrumentation Laboratory CO2004—
†K070005Hemosil Recombiplastin 2GInstrumentation Laboratory CO20071
†K213464HemosIL Liquid Anti-XaInstrumentation Laboratory CO20222

Also cleared against K150877: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 2 companies; a new generation was cleared every 3.4 years on median.
  • 5 of the 6 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K150877.

How does its category compare?

All JPA devices

JPA System, Multipurpose For In Vitro Coagulation Studies: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · JPA

3in 2025

2007: 12008: 22009: 62010: 12011: 12013: 12015: 22016: 62017: 42018: 12019: 32021: 12022: 12023: 32024: 12025: 32026 (partial year): 1
2007high 6 (2009) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JPA

30in 2025

2009: 91 days median2016: 114 days median2017: 117 days median2019: 175 days median2023: 506 days median2025: 30 days median
2007high 506 (2023) · low 30 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JPA

1in 2020

2007: 12010: 62011: 42012: 12016: 32020: 12026 (partial year): 1
2007high 6 (2010) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JPA

11in 2025

2007: 1,7442008: 9182009: 1,3632010: 7272011: 1612012: 522013: 432014: 482015: 452016: 62017: 152018: 392019: 272020: 182021: 72022: 92023: 112024: 82025: 11
2007high 1,744 (2007) · low 6 (2016)2025

MAUDE reports naming product code JPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—11,744
20082—0918
200969101,363
20101—6727
20111—4161
20120—152
20131—043
20140—048
20152—045
2016611436
20174117015
20181—039
20193175027
20200—118
20211—07
20221—09
20233506011
20241—08
2025330011
20261—1—

What is it indicated for?

The ACL TOP 970 CL is a bench top, fully automated, random access analyzer designed specifically for in vitro diagnostic use by health care professionals in a clinical laboratory for coagulation and/or fibrinolysis testing in the assessment of thrombosis and/or hemostasis.

The system provides results for both direct measurements and calculated parameters.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K233790: Acl Top 970 CL.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K233790

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026